Xiangyu P. Zhong

148 Baojian Street
Harbin, 150086, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Mitophagy in Hepatic Ischemia-Reperfusion Injury: From Mitochondrial Dysfunction to Therapeutic Targeting.

Mitophagy in Hepatic Ischemia-Reperfusion Injury: From Mitochondrial Dysfunction to Therapeutic Targeting.

Journal: Biomolecules
Published: April 27, 2026

The depletion of serine beta-lactamase-like protein (LACTB) ameliorates metabolic dysfunction-associated steatotic liver disease by reducing ubiquitin-mediated degradation of carnitine palmitoyltransferase 2.

The depletion of serine beta-lactamase-like protein (LACTB) ameliorates metabolic dysfunction-associated steatotic liver disease by reducing ubiquitin-mediated degradation of carnitine palmitoyltransferase 2.

Journal: Diabetes, obesity & metabolism
Published: September 23, 2025

PRC1 promotes MAFLD progression by regulating glycolysis/lactylation axis and forming a positive feedback loop.

PRC1 promotes MAFLD progression by regulating glycolysis/lactylation axis and forming a positive feedback loop.

Journal: The Journal of nutritional biochemistry
Published: May 21, 2025

Exosomal Non-Coding RNAs in Pancreatic Cancer: From Mechanisms to Clinical Applications.

Exosomal Non-Coding RNAs in Pancreatic Cancer: From Mechanisms to Clinical Applications.

Journal: Oncology research
Published: March 31, 2025

Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression.

Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression.

Journal: Journal of clinical and translational hepatology
Published: August 23, 2024

A Novel 167-Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination.

A Novel 167-Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 05, 2024

Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway.

Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway.

Journal: Journal of lipid research
Published: August 05, 2024

Polyribonucleotide nucleotidyltransferase 1 participates in metabolic-associated fatty liver disease pathogenesis by affecting lipid metabolism and mitochondrial homeostasis.

Polyribonucleotide nucleotidyltransferase 1 participates in metabolic-associated fatty liver disease pathogenesis by affecting lipid metabolism and mitochondrial homeostasis.

Journal: Molecular metabolism
Published: July 03, 2024

Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology.

Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology.

Journal: Frontiers in oncology
Published: June 15, 2024

Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research.

Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research.

Journal: Frontiers in nutrition
Published: May 02, 2024

ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2.

ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2.

Journal: Cancer gene therapy
Published: March 16, 2024

Feedback loop LINC00511-YTHDF2-SOX2 regulatory network drives cholangiocarcinoma progression and stemness.

Feedback loop LINC00511-YTHDF2-SOX2 regulatory network drives cholangiocarcinoma progression and stemness.

Journal: MedComm
Published: March 02, 2024
Showing 1-12 of 49

Last Updated: 09/26/2026